phosphoglucomutase 2-Like 1 (PGM2L1) (N-Term) Peptide
Quick Overview for phosphoglucomutase 2-Like 1 (PGM2L1) (N-Term) Peptide (ABIN8108113)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- PGM2L1 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PGM2L1 antibody ( ARP55658_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PGM2L1 (phosphoglucomutase 2-Like 1 (PGM2L1))
-
Background
-
Background Information: PGM2L1 is the Glucose 1,6-bisphosphate synthase using 1,3-bisphosphoglycerate as a phosphate donor and a series of 1-phosphate sugars as acceptors, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1-phosphate. 5 or 6-phosphosugars are bad substrates, with the exception of glucose 6-phosphate. PGM2L1 also synthesizes ribose 1,5-bisphosphate. PGM2L1 has only low phosphopentomutase and phosphoglucomutase activities.
Alternative Symbols: BM32A, FLJ32029
-
Molecular Weight
- 70kDa
-
Gene ID
- 283209
-
NCBI Accession
- NP_775853
-
UniProt
- Q6PCE3
Target
-